Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Metabolic Syndrome × Pioglitazone × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 2 Diabetes Mellitus, Type 2 2 Diabetes Mellitus 2 Pancreatic Neoplasms 1 Metabolic Syndrome 1 Inflammation 1 Hypogonadism 1

Interventions

semaglutide 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Vascular Stiffness 1 Topiramate 1 Tirzepatide 1 Testosterone 1 Qsymia 1 Pulse Wave Analysis 1 Pioglitazone 1 Phentermine 1 Observation 1 Naltrexone 1 Medical History Taking 1 Liraglutide 1 Human Growth Hormone 1 Hematologic Tests 1 Growth Hormone 1 Gonadotropin-Releasing Hormone 1 Glucagon-Like Peptide-1 Receptor 1 Gastric Bypass 1 Electrocardiography 1 Echocardiography 1 Diethylpropion 1 Dietary Approaches To Stop Hypertension 1 DNA 1 Colonoscopy 1 Bupropion 1 Blood Specimen Collection 1 Blood Pressure 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00743327 2012-08-06

ADT

National Institutes of Health Clinical Center (CC)

Diabetes Mellitus, Hypogonadism, Inflammation, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡